13-Deoxyadriamycin hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug Name13-Deoxyadriamycin hydrochloride
Drug Alias NameGPX-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGem Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGem Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank